Partnerships that push boundaries

Lilly employee in a lab using scientific equipment

Groundbreaking discoveries require persistence, bold ideas, and partnership.

That’s why we support promising, hard science throughout its many
stages of development, leveraging our expertise to help turn
meaningful visions into breakthroughs.

100+

numeric-tile, title-fs-48px, description-fs-16px
Discovery or molecule deals made in the last 5 years

70+

numeric-tile, title-fs-48px, description-fs-16px
actively managed alliances

~50%

numeric-tile, title-fs-48px, description-fs-16px
of new product launches in the last decade enabled by external innovation
style
background-primary-red
additionalPadding
narrow
Lilly employee with her hand on a machine
style
background-none
additionalPadding
narrow

Accelerating bold
science at every stage

People around the world are waiting for innovation to deliver life-changing medicines. That requires smart risks that support bold external science. That approach along with trust, transparency and our 150+ years of expertise, fuels every collaboration we enter.

Every partnership is unique because every company’s science is unique. We can engage companies across various stages, modalities or therapeutic areas to offer leading capabilities, tools and resources that eliminate obstacles and rapidly advance breakthroughs in health.

With a range of flexible offerings and depth of experience, we enable groundbreaking science at every point of the journey, with two pathways to partner.
extra-styles
offset
style
two-col-50-50
Collection of Lilly heritage insulins

Corporate business development

card, titleone-fs-28px, description-fs-14px, ctaselection-link, ctatarget-sametab, ctaexitinterstitial-select, ctanumber-one
We seek the most powerful science for strategic partnerships, licensing and potential acquisitions in our core therapeutic areas. Through our Search & Evaluation, Transactions and Alliance & Innovation Management teams, we operate on the frontiers of medicine development.
Learn more about who we are
Three pipettes with a droplet of solution from one

Lilly Catalyze360

card, titleone-fs-28px, description-fs-14px, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-country, ctanumber-one
Built to engage biotechs at the earliest stages and agnostic of therapeutic area, we offer a global investment arm with Lilly Ventures; lab facilities and scientific engagement through Lilly Gateway Labs; and R&D solutions via Lilly ExploR&D.
Learn more about our solutions
style
background-none
additionalPadding
narrow
additionalMargin
none
relatedlink, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-country
Connect with us
We're ready to hear more about your promising work.
relatedlink, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-outside-country
Partnering events and conferences
Learn where we'll be for upcoming events.
style
background-primary-red
additionalPadding
narrow
CMAT-26550 | May 2026
style
background-none
additionalPadding
narrow